Pictet Asset Management (Switzerland)’s Integra LifeSciences IART Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$370K	Hold	8,989	–	–	﹤0.01%	1399
2023 Q1	$516K	Buy	8,989 +4	+0%	+$225	﹤0.01%	1237
2022 Q4	$504K	Buy	+8,985	New	+$457K	﹤0.01%	1246
2022 Q3	–	Sell	-4,700	Closed	-$254K	–	1588
2022 Q2	$254K	Hold	4,700	–	–	﹤0.01%	1348
2022 Q1	$302K	Hold	4,700	–	–	﹤0.01%	1362
2021 Q4	$315K	Hold	4,700	–	–	﹤0.01%	1375
2021 Q3	$322K	Buy	+4,700	New	+$332K	﹤0.01%	1374

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IART Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Integra LifeSciences (IART) position steady in Q2 2023 at 8,989 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

Pictet Asset Management (Switzerland) first reported a position in IART in Q3 2021 and has held it in 7 quarters since. The position peaked at $516K in Q1 2023. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

Pictet Asset Management (Switzerland) held 8,989 shares of Integra LifeSciences worth $370K as of Q2 2023.
Pictet Asset Management (Switzerland) left its Integra LifeSciences share count unchanged in Q2 2023.
Integra LifeSciences made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1399 holding.
Pictet Asset Management (Switzerland) first reported a position in Integra LifeSciences in Q3 2021 and has held it in 7 quarters since.
Pictet Asset Management (Switzerland)'s Integra LifeSciences position peaked at $516K in Q1 2023.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.